Literature DB >> 33430411

Can Previous Associations of Single Nucleotide Polymorphisms in the TLR2, NOD1, CXCR5, and IL10 Genes in the Susceptibility to and Severity of Chlamydia trachomatis Infections Be Confirmed?

Jelmer B Jukema1, Bernice M Hoenderboom1,2, Birgit H B van Benthem2, Marianne A B van der Sande2,3,4, Henry J C de Vries5,6, Christian J P A Hoebe7,8, Nicole H T M Dukers-Muijrers7,8, Caroline J Bax9, Servaas A Morré1,10, Sander Ouburg1.   

Abstract

Clear inter-individual differences exist in the response to C. trachomatis (CT) infections and reproductive tract complications in women. Host genetic variation like single nucleotide polymorphisms (SNPs) have been associated with differences in response to CT infection, and SNPs might be used as a genetic component in a tubal-pathology predicting algorithm. Our aim was to confirm the role of four genes by investigating proven associated SNPs in the susceptibility and severity of a CT infection. A total of 1201 women from five cohorts were genotyped and analyzed for TLR2 + 2477 G > A, NOD1 + 32656 T -> GG, CXCR5 + 10950 T > C, and IL10 - 1082 A > G. Results confirmed that NOD1 + 32656 T ->GG was associated with an increased risk of a symptomatic CT infection (OR: 1.9, 95%CI: 1.1-3.4, p = 0.02), but we did not observe an association with late complications. IL10 - 1082 A > G appeared to increase the risk of late complications (i.e., ectopic pregnancy/tubal factor infertility) following a CT infection (OR = 2.8, 95%CI: 1.1-7.1, p = 0.02). Other associations were not found. Confirmatory studies are important, and large cohorts are warranted to further investigate SNPs' role in the susceptibility and severity of a CT infection.

Entities:  

Keywords:  Chlamydia trachomatis; SNP; severity; single nucleotide polymorphism; susceptibility

Year:  2021        PMID: 33430411      PMCID: PMC7827792          DOI: 10.3390/pathogens10010048

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  31 in total

1.  IL-10 polymorphism and cell-mediated immune response to Chlamydia trachomatis.

Authors:  H Ohman; A Tiitinen; M Halttunen; S Birkelund; G Christiansen; P Koskela; M Lehtinen; J Paavonen; H-M Surcel
Journal:  Genes Immun       Date:  2006-04       Impact factor: 2.676

2.  An investigation of polymorphism in the interleukin-10 gene promoter.

Authors:  D M Turner; D M Williams; D Sankaran; M Lazarus; P J Sinnott; I V Hutchinson
Journal:  Eur J Immunogenet       Date:  1997-02

3.  Potential protective effect of a G>A SNP in the 3'UTR of HLA-A for Chlamydia trachomatis symptomatology and severity of infection.

Authors:  Marleen E Jansen; Ivan Branković; Joke Spaargaren; Sander Ouburg; Servaas A Morré
Journal:  Pathog Dis       Date:  2015-12-09       Impact factor: 3.166

4.  B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice.

Authors:  Patrizia Scapini; Chrystelle Lamagna; Yongmei Hu; Karim Lee; Qizhi Tang; Anthony L DeFranco; Clifford A Lowell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-12       Impact factor: 11.205

Review 5.  Chlamydia trachomatis infections and subfertility: opportunities to translate host pathogen genomic data into public health.

Authors:  J A Lal; J Malogajski; S P Verweij; P de Boer; E Ambrosino; A Brand; S Ouburg; S A Morré
Journal:  Public Health Genomics       Date:  2013-03-18       Impact factor: 2.000

Review 6.  Biology of interleukin-10.

Authors:  Robert Sabat; Gerald Grütz; Katarzyna Warszawska; Stefan Kirsch; Ellen Witte; Kerstin Wolk; Jens Geginat
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-05       Impact factor: 7.638

7.  Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection.

Authors:  Toni Darville; Joshua M O'Neill; Charles W Andrews; Uma M Nagarajan; Lynn Stahl; David M Ojcius
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

8.  TLR2, TLR4 and TLR9 genotypes and haplotypes in the susceptibility to and clinical course of Chlamydia trachomatis infections in Dutch women.

Authors:  Stephan P Verweij; Ouafae Karimi; Jolein Pleijster; Joseph M Lyons; Henry J C de Vries; Jolande A Land; Servaas A Morré; Sander Ouburg
Journal:  Pathog Dis       Date:  2015-11-13       Impact factor: 3.166

9.  The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women.

Authors:  B M Hoenderboom; A A M van Oeffelen; B H B van Benthem; J E A M van Bergen; N H T M Dukers-Muijrers; H M Götz; C J P A Hoebe; A A Hogewoning; F R M van der Klis; D van Baarle; J A Land; M A B van der Sande; M G van Veen; F de Vries; S A Morré; I V F van den Broek
Journal:  BMC Infect Dis       Date:  2017-04-11       Impact factor: 3.090

10.  Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial.

Authors:  Bernice M Hoenderboom; Birgit H B van Benthem; Jan E A M van Bergen; Nicole H T M Dukers-Muijrers; Hannelore M Götz; Christian J P A Hoebe; Arjan A Hogewoning; Jolande A Land; Marianne A B van der Sande; Servaas A Morré; Ingrid V F van den Broek
Journal:  Sex Transm Infect       Date:  2019-01-03       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.